Fanconi Anemia Panel
Use
The Fanconi Anemia Panel is designed for individuals with features indicative of Fanconi anemia, including clinical or suspected diagnosis. It is also suitable for individuals who have developed bone marrow failure, hematologic malignancies, or solid tumors. Moreover, it can aid those with a positive DEB/MMC chromosome breakage assay in diagnosing Fanconi anemia.
Special Instructions
Stat testing available with an added surcharge, provided the report is delivered within 16 days of submission and that the blood sample was sent. Exome-wide CNV analysis is available as an add-on for PGxome-based or custom panels, but not for PG-Select panels or via Sanger sequencing. Patients should consult specific ordering instructions on the PreventionGenetics website.
Limitations
This test has been developed and its performance characteristics have been determined by PreventionGenetics, LLC following CAP and CLIA regulations. However, it has not been cleared or approved by the FDA. The test results should be interpreted alongside clinical evaluations and other laboratory findings for comprehensive patient assessment.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided